Supported by

Tricuspid / Pulmonary valve

Find all the latest content on tricuspid or pulmonary valve published on this website.

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

466 results

TAVI - computer simulation and pre-procedural modelling

19 Nov 2023 – From PCR London Valves 2023

TAVI - computer simulation and pre-procedural modelling

19 Nov 2023 – From PCR London Valves 2023

TAVI in bicuspid anatomy - Part 1

19 Nov 2023 – From PCR London Valves 2023

Delve into the complexities of TAVI within bicuspid anatomy through this selection of cases: encounter a challenging scenario with a bicuspid aortic valve, where the ejection fraction is -14%, coupled with left ventricle thrombus and an aortic valve calcium score reaching 11,000, learn more about the...

TAVI in bicuspid anatomy - Part 1

Tricuspid TEER - Part 1

19 Nov 2023 – From PCR London Valves 2023

Gain insights into Tricuspid Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the congestion patterns observed in severe tricuspid regurgitation and gain a deeper understanding of transcatheter treatment modalities, delve into the baseline characteristics of the Tri.Fr randomized trial on treating tricuspid regurgitation, witness the application...

Tricuspid TEER - Part 1

Rapid-fire - Nightmares in the cathlab - Part 1

19 Nov 2023 – From PCR London Valves 2023

Discover intriguing cases featured in the PCR London Valves 2023 course: learn about a rare malfunction in a Mitral TEER device, delve into the complexities surrounding a self-expanding valve TAVI where embolisation poses a threat towards the left ventricle, explore the challenges associated with TAVR in...

Rapid-fire - Nightmares in the cathlab - Part 1

Rapid-fire - Challenging TAVI procedures - Part 1

19 Nov 2023 – From PCR London Valves 2023

Discover challenging TAVI procedures in this session, including: TAVI in a small aortic annulus with chimney stenting, TAVI with ACURATE Neo 2 and coronary protection in a horizontal aorta with low coronary height, simultaneous kissing balloon inflation technique for effective coronary protection during TAVI, and much...

Rapid-fire - Challenging TAVI procedures - Part 1

Rapid-fire - Challenging tricuspid procedures

19 Nov 2023 – From PCR London Valves 2023

Discover challenging tricuspid procedures in this session: learn more about the struggle of recurrent heart failure in the presence of a left ventricular assist device, gain insights into single-stage percutaneous replacement of native pulmonary and tricuspid valves, navigate the complexities of managing bioprosthetic tricuspid stenosis post-cardiac...

Rapid-fire - Challenging tricuspid procedures

Tricuspid valve interventions - Case studies

19 Nov 2023 – From PCR London Valves 2023

Explore a diverse range of tricuspid valve interventions through various case studies such as the multimodality percutaneous treatment of severe tricuspid regurgitation, Triclip subacute single leaflet detachment, bicaval valve implantation and more.

Controversies in atrioventricular valves - The Heart Team ring, Vol II

19 Nov 2023 – From PCR London Valves 2023

This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.

Controversies in atrioventricular valves

Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...

19 Nov 2023 – From PCR London Valves 2023

Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023: 

  • TRISCEND study two-year outcomes: transfemoral TTVR
  • Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
  • One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
  • TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
  • Real-world...
Tricuspid Late-Breaking Trials